Stay updated on Pembrolizumab & Endocrine Therapy Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Endocrine Therapy Clinical Trial page.

Latest updates to the Pembrolizumab & Endocrine Therapy Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe page now displays Revision: v3.4.3, replacing the previous Revision: v3.4.2.SummaryDifference0.0%

- Check15 days agoChange DetectedResults posting details were added, including dates when results were first posted. The study documents were expanded with links to the protocol and informed consent forms, and the outcome measures were updated to specify RECIST-based endpoints and include multiple drug name synonyms.SummaryDifference5%

- Check29 days agoChange DetectedThe change is a minor version update (from v3.4.1 to v3.4.2) with no impact on study data, eligibility, or displayed content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check37 days agoChange DetectedThe footer revision changed from v3.4.0 to v3.4.1; there is no change to core content such as study details, eligibility criteria, or trial results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check44 days agoChange DetectedThe page now includes a 'Show glossary' option and displays 'Last Update Submitted that Met QC Criteria' along with 'No FEAR Act Data' and 'Revision: v3.4.0'. The previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed.SummaryDifference0.2%

- Check59 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4 (metadata only), and this does not affect study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab & Endocrine Therapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Endocrine Therapy Clinical Trial page.